Skip to main content
. Author manuscript; available in PMC: 2024 Sep 3.
Published in final edited form as: Lancet Digit Health. 2024 Mar;6(3):e187–e200. doi: 10.1016/S2589-7500(23)00252-2

Table 1:

Baseline characteristics for young people at risk for HIV in Los Angeles and New Orleans by intervention group and total analytic sample

AMMI only (n=313) AMMI plus peer support (n=205) AMMI plus coaching (n=196) AMMI plus peer support and coaching (n=181) Overall (n=895)
Mean age, years (SD) 21·05 (2·07) 21·00 (2·27) 20·88 (2·19) 21·19 (2·12) 21·03 (2·15)
Sex
 Male 286 (91%) 194 (95%) 180 (92%) 170 (94%) 830 (93%)
 Female 27 (9%) 11 (5%) 16 (8%) 11 (6%) 65 (7%)
Gender*
 Cisgender 249 (80%) 173 (84%) 147 (75%) 155 (86%) 724 (81%)
 Transgender man 20 (6%) 9 (4%) 13 (7%) 6 (3%) 48 (5%)
 Transgender woman 19 (6%) 15 (7%) 17 (9%) 8 (4%) 59 (7%)
 Gender-diverse man 18 (6%) 6 (3%) 16 (8%) 7 (4%) 47 (5%)
 Gender-diverse woman 7 (2%) 2 (1%) 3 (2%) 5 (3%) 17 (2%)
Sexual orientation
 Gay 171 (55%) 121 (59%) 102 (52%) 107 (59%) 501 (56%)
 Bisexual 78 (25%) 51 (25%) 56 (29%) 49 (27%) 234 (26%)
 Pansexual 28 (9%) 9 (4%) 18 (9%) 11 (6%) 66 (7%)
 Heterosexual 17 (5%) 8 (4%) 11 (6%) 5 (3%) 41 (5%)
 Queer 12 (4%) 13 (6%) 6 (3%) 6 (3%) 37 (4%)
 Other non-heterosexual 7 (2%) 3 (1%) 3 (2%) 3 (2%) 16 (2%)
Race or ethnicity
 Black or African American 141 (45%) 79 (39%) 77 (39%) 65 (36%) 362 (40%)
 Latinx or Hispanic 80 (26%) 58 (28%) 61 (31%) 58 (32%) 257 (29%)
 White (non-Hispanic) 60 (19%) 47 (23%) 33 (17%) 44 (24%) 184 (21%)
 Asian or Pacific Islander 20 (6%) 14 (7%) 10 (5%) 9 (5%) 53 (6%)
 Other or mixed background 12 (4%) 7 (3%) 15 (8%) 5 (3%) 39 (4%)
City
 Los Angeles, CA, USA 185 (59%) 127 (62%) 120 (61%) 114 (63%) 546 (61%)
 New Orleans, LA, USA 128 (41%) 78 (38%) 76 (39%) 67 (37%) 349 (39%)
Education
 Below high school 55 (18%) 30 (15%) 28 (14%) 24 (13%) 137 (15%)
 High school or equivalent 77 (25%) 41 (20%) 47 (24%) 41 (23%) 206 (23%)
 Some higher education 144 (46%) 94 (46%) 100 (51%) 81 (45%) 419 (47%)
 Completed higher education 34 (11%) 35 (17%) 19 (10%) 31 (17%) 119 (13%)
Income above federal poverty level (2021) 101 (32%) 74 (36%) 79 (40%) 54 (30%) 308 (34%)
Insurance status
 Insured 235 (75%) 166 (81%) 147 (75%) 139 (77%) 687 (77%)
 Uninsured or unsure 78 (25%) 39 (19%) 49 (25%) 42 (23%) 208 (23%)
Sexual risk and protective behaviours
 Sexually transmitted infection (in lifetime) 104 (33%) 71 (35%) 69 (35%) 64 (35%) 308 (34%)
 Sexually transmitted infection (in past 4 months) 78 (25%) 46 (22%) 49 (25%) 48 (27%) 221 (25%)
 Condomless sex with partner with HIV (in lifetime)§ 27/305 (9%) 16/192 (8%) 14/184 (8%) 19/176 (11%) 76/857 (9%)
 Condomless anal sex in past year 212 (68%) 120 (59%) 131 (67%) 128 (71%) 591 (66%)
 100% condom use with all partners (in lifetime)§ 67/305 (22%) 49/192 (26%) 30/184 (16%) 30/176 (17%) 176/857 (21%)
 100% condom use with all partners (in past 4 months) 118/275 (43%) 72/173 (42%) 63/163 (39%) 58/157 (37%) 311/768 (40%)
 No sexual activity (in past 4 months) 38 (12%) 32 (16%) 33 (17%) 24 (13%) 127 (14%)
 Mean number of recent sexual partners (in past 4 months; SD) 3·70 (6·99) 5·46 (19·25) 3·09 (3·95) 5·06 (15·66) 4·25 (12·51)
 PrEP use (in lifetime) 49 (16%) 38 (19%) 44 (22%) 36 (20%) 167 (19%)
 PrEP use (current) 34 (11%) 23 (11%) 26 (13%) 18 (10%) 101 (11%)
 PEP use (in lifetime)* 15 (5%) 6 (3%) 17 (9%) 15 (8%) 53 (6%)
 PEP use (in past 4 months)* 4 (1%) 3 (1%) 8 (4%) 9 (5%) 24 (3%)
 Sex exchange (in lifetime)* 93 (30%) 43 (21%) 40 (20%) 41 (23%) 217 (24%)
Substance use
 Cannabis use (in past 4 months) 231 (74%) 140 (68%) 142 (72%) 135 (75%) 648 (72%)
 AUDIT-C hazardous drinking 126 (40%) 93 (45%) 78 (40%) 73 (40%) 370 (41%)
 Opioid use (in past 4 months) 13 (4%) 13 (6%) 10 (5%) 14 (8%) 50 (6%)
 Stimulant use (cocaine or methamphetamines) 69 (22%) 49 (24%) 47 (24%) 42 (23%) 207 (23%)
 Poppers (nitrite inhalants) use (in lifetime)* 74 (24%) 68 (33%) 58 (30%) 60 (33%) 260 (29%)
Mental health
 Suicide attempt (in lifetime) 103 (33%) 50 (24%) 63 (32%) 51 (28%) 267 (30%)
 PHQ-9 depression symptoms (clinical cutoff) 98 (31%) 62 (30%) 57 (29%) 55 (30%) 272 (30%)
 GAD-7 anxiety symptoms (clinical cutoff) 124 (40%) 70 (34%) 63 (32%) 65 (36%) 322 (36%)
 Mental health hospitalisation (in lifetime)* 94 (30%) 36 (18%) 45 (23%) 31 (17%) 206 (23%)
Homelessness (in lifetime)* 140 (45%) 58 (28%) 57 (29%) 62 (34%) 317 (35%)
Incarceration (in lifetime)* 62 (20%) 26 (13%) 23 (12%) 30 (17%) 141 (16%)
Intimate partner violence (in lifetime)* 108 (35%) 57 (28%) 59 (30%) 49 (27%) 273 (31%)
Support services use (in past 4 months)* 158 (50%) 83 (40%) 60 (31%) 57 (31%) 358 (40%)

Data are n (%) or n/N (%) unless otherwise stated. Some percentages do not total 100% due to missing values. AMMI=automated text messaging and monitoring. AUDIT-C=alcohol use disorders identification test consumption. PrEP=pre-exposure prophylaxis. PEP=post-exposure prophylaxis. PHQ-9=Patient Heath Questionnaire-9. GAD-7=Generalized Anxiety Disorder-7.

*

χ2 tests of independence for imbalances at baseline between groups p<0·05.

Sexual orientation is given as was reported at baseline. Men who have sex with men identifying as heterosexual were classified as gay or bisexual on the basis of behavioural reports for the longitudinal analysis.

Includes young people specifying Black non-Hispanic and 64 people reporting Black Hispanic or Black and other or mixed background, where other or mixed background excludes Black or African American.

§

Denominators exclude missing data, refusals, and participants not reporting vaginal or anal intercourse in their lifetime.

Denominators exclude participants reporting no sexual activity in past 4 months at baseline.